Cargando…

Novel Uses for Lipid-Lowering Agents

Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales: May, Megan Brafford, Glode, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226310/
https://www.ncbi.nlm.nih.gov/pubmed/28090367
_version_ 1782493634255388672
author May, Megan Brafford
Glode, Ashley
author_facet May, Megan Brafford
Glode, Ashley
author_sort May, Megan Brafford
collection PubMed
description Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell proliferation; enhanced apoptosis; and modulation of inflammation, endothelial function, and angiogenesis. In cancer specifically, experimental studies have found that statins may induce cancer cell apoptosis and inhibit tumor growth, angiogenesis, and metastasis. These mechanisms have steered researchers into evaluating the possible benefit of statins in the prevention and treatment of malignancies. This review will discuss the literature supporting the use of statins to prevent and treat cancer.
format Online
Article
Text
id pubmed-5226310
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-52263102017-01-15 Novel Uses for Lipid-Lowering Agents May, Megan Brafford Glode, Ashley J Adv Pract Oncol Review Article Statin use leads to a reduction in the downstream products of the mevalonate pathway. Knowledge of this pathway has led scientists to investigate the role of statins in cancer prevention and treatment. Statins appear to possess a variety of pleiotropic effects, including inhibition of cell proliferation; enhanced apoptosis; and modulation of inflammation, endothelial function, and angiogenesis. In cancer specifically, experimental studies have found that statins may induce cancer cell apoptosis and inhibit tumor growth, angiogenesis, and metastasis. These mechanisms have steered researchers into evaluating the possible benefit of statins in the prevention and treatment of malignancies. This review will discuss the literature supporting the use of statins to prevent and treat cancer. Harborside Press 2016-03 2016-03-01 /pmc/articles/PMC5226310/ /pubmed/28090367 Text en Copyright © 2016, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
May, Megan Brafford
Glode, Ashley
Novel Uses for Lipid-Lowering Agents
title Novel Uses for Lipid-Lowering Agents
title_full Novel Uses for Lipid-Lowering Agents
title_fullStr Novel Uses for Lipid-Lowering Agents
title_full_unstemmed Novel Uses for Lipid-Lowering Agents
title_short Novel Uses for Lipid-Lowering Agents
title_sort novel uses for lipid-lowering agents
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226310/
https://www.ncbi.nlm.nih.gov/pubmed/28090367
work_keys_str_mv AT maymeganbrafford novelusesforlipidloweringagents
AT glodeashley novelusesforlipidloweringagents